Our technologies unlock thousands of novel (chiral) building blocks and novel variants of privileged scaffolds. By improving the access to 3D chemical space, our goal is to help accelerate the discovery and development of high quality drugs.
INTEGRATE LCC’s UNIQUE COMPOUNDS IN YOUR R&D PROGRAMME TO REACH NEW OPPORTUNITIES.
LCC has a catalogue and pipeline that comprise diverse fragments, scaffolds and building blocks, accessible using our proprietary technologies and expertise. Our compounds are following two major directions:
Novel variants of privileged scaffolds
Representative examples of LCC’s main scaffolds
For more examples of our DEL scaffolds categories and/or a customised sd-file, please contact our BD Manager, Dr. Marie Hoffmann at email@example.com.
ACCESS HIGH sp3 FRACTION COMPOUNDS
Diverse array of heterocyclic compounds.
Extended selection of 3D-rich synthons.
Variety of substituents (Ar, F, Alk, amide, …) and synthetic handles (amine, ester, acid, …).
Mono / Di / Tri functionalized compounds.
Low molecular weight.
Racemic and chirally-pure material available.
Choose from LCC's PRODUCT CATEGORIES
LCC’s collection contains numerous compounds that are specifically chosen and designed according to leading applications in drug discovery.
Besides new building blocks, we are also focussing on variants of privileged scaffolds, available from mg to kg scale, to make sure we can assist you at each and every step of you programme(s).
Thus, piperidines and pyrrolidines are ubiquitous scaffolds in small molecule drugs (>60% of the marketed small molecule drugs bare these moieties). The importance of LCC’s compounds can be highlighted by their presence in several of the top 200 pharmaceutical products sold in 2018.
If the compounds you’re looking for aren’t yet in our pipeline, but align with our expertise, our R&D team is ready to tackle whatever comes next.
MOtM - November 2020
Lead-like Virtual Library of 3D-fragments
order to create a Ro4 lead like virtual library that is drug like novel diverse 3D rich and enantiomerically pure LCC collaborated with one of the best in class...
June 2020 - Award
PROFESSOR XIAO WINS 2020 TILDEN PRIZE
Congratulations to Professor Jianliang Xiao, recipient of the prestigious 2020 Tilden Prize from the Royal Society of Chemistry. Having him as a distinguished member of our Scientific Advisory Board is a blessing. Thank you Professor!
News - April 2020 - Funding
NEW £2.25m FUNDING AGREEMENT
Liverpool-headquartered chemical technology business receives £2.25m funding to accelerate its mission
Liverpool ChiroChem, an international chemical technology business whose products form the building blocks to the research and development of new......
News - November 2019 - New Partnership
CRESSET AND LIVERPOOL CHIROCHEM ANNOUNCE COLLABORATION
Cresset, provider of software and contract research services for small molecule drug discovery, and LCC a chemical technology innovator that produces chiral...